Solstice Advanced Materials Inc.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 11 February 2026: press release. Guidance figures: 6 new. The quarter’s numbers.

Read the filing

Key takeaways

• Quarterly net sales rose 8 percent: Net sales were $987 million against $913 million a year earlier; organic net sales rose 6% on favorable pricing and volume growth. Source
• Full-year margin fell on refrigerants mix: Full-year Adjusted Standalone EBITDA was $957 million, down 4%; the 24.6% margin fell 176 basis points on Refrigerants product mix from the LGWP transition. Source
• Refrigerants sales rose 20 percent: Refrigerants sales were $367 million, up 20%, on higher volume and pricing; the RAS segment grew 10% to $710 million. Source
• Nuclear sales rose 39 percent: Alternative Energy Services sales were $111 million, up 39%, on favorable pricing and higher volumes. Source
• Segment margin fell 1,225 basis points: RAS segment adjusted EBITDA was $190 million, down 25%; the 26.8% margin fell on transitory costs, Healthcare Packaging under-absorption and LGWP refrigerant mix, partly offset by pricing and volume. Source
• Capital spending rose 38 percent: Full-year capital expenditures were $408 million, up 38%; Adjusted Standalone EBITDA less capex fell 21% to $549 million. Source
• Full-year 2026 sales and EBITDA guided: Full-year 2026 guidance: net sales of $3.9 billion to $4.1 billion and Adjusted EBITDA of $975 million to $1,025 million. Source

“I’m pleased to report Solstice’s strong fourth quarter results, with better-than-anticipated results reinforcing the value of our differentiated technology platform and product offerings,”

David Sewell, President and Chief Executive Officer

Guidance

What changed from last quarter

• New guidance: Guidance for full-year and first-quarter 2026 was provided for net sales, Adjusted EBITDA, Adjusted Diluted EPS and capital expenditures. Source
• New: The company began a quarterly cash dividend; the Board approved $0.075 per share on February 9, 2026. Source
• New: The company announced the day before the release an effort to expand its nuclear conversion business. Source

Results and growth drivers

• Quarterly net sales rose 8 percent: Net sales were $987 million against $913 million a year earlier; organic net sales rose 6% on favorable pricing and volume growth. Source
• Net income fell on costs and interest: Net income attributable to Solstice was $41 million against $133 million; the company cited higher operating costs, net interest expense and non-controlling interest. Source
• Full-year sales rose 3 percent: Full-year net sales were $3.9 billion, with organic growth of 2% from Refrigerants volume and pricing, Electronic Materials demand and Research & Performance Chemicals pricing. Source
• Full-year margin fell on refrigerants mix: Full-year Adjusted Standalone EBITDA was $957 million, down 4%; the 24.6% margin fell 176 basis points on Refrigerants product mix from the LGWP transition. Source

Segments and regions

• Refrigerants sales rose 20 percent: Refrigerants sales were $367 million, up 20%, on higher volume and pricing; the RAS segment grew 10% to $710 million. Source
• Nuclear sales rose 39 percent: Alternative Energy Services sales were $111 million, up 39%, on favorable pricing and higher volumes. Source
• Healthcare Packaging sales fell 25 percent: Healthcare Packaging sales were $52 million, down 25%, on customer destocking; Building Solutions & Intermediates fell 5% to $181 million. Source
• Electronic Materials sales rose 19 percent: Electronic Materials sales were $112 million, up 19%, on volume growth; the ESM segment grew 4% to $277 million. Source
• Safety & Defense sales fell on order timing: Safety & Defense Solutions sales fell 10% to $43 million on lower volumes from order timing. Source
• Research & Performance Chemicals sales declined: Research & Performance Chemicals sales were $121 million, down 3%, on lower construction-related demand. Source

“We are seeing continued momentum and demand in our businesses aligned with key secular growth trends, such as data centers, A.I., and nuclear energy,”

David Sewell, President and Chief Executive Officer

Costs, margins and pricing

• Segment margin fell 1,225 basis points: RAS segment adjusted EBITDA was $190 million, down 25%; the 26.8% margin fell on transitory costs, Healthcare Packaging under-absorption and LGWP refrigerant mix, partly offset by pricing and volume. Source
• ESM margin reflected downtime: ESM segment adjusted EBITDA was $51 million, down 11%; the 18.4% margin fell 294 basis points on transitory costs and expected plant downtime. Source
• Corporate expenses rose to $52 million: Corporate expenses were $52 million, up from $48 million; estimated incremental standalone cost adjustments were negligible, compared with $26 million a year earlier. Source

Capital, cash and returns

• Capital spending rose 38 percent: Full-year capital expenditures were $408 million, up 38%; Adjusted Standalone EBITDA less capex fell 21% to $549 million. Source
• Cash conversion fell to 57 percent: Cash conversion was 57.4%, down from 70.3% a year earlier. Source
• Net leverage about 1.5 times: Long-term debt was $2.0 billion against cash of $534 million; total liquidity was about $1.5 billion, including $1.0 billion of revolving credit availability. Source

“As we move into 2026, we are confident in our ability to build on our track record of operational excellence and continue unleashing growth across the business,”

David Sewell, President and Chief Executive Officer

Strategy and investment

• Capital allocated with discipline: Management said it remains focused on allocating capital with discipline while investing in capacity, technology and operating efficiency. Source
• Growth focus on secular trends: Management named data centers, A.I. and nuclear energy as secular growth trends behind demand, and cited its differentiated technology platform. Source
• Shareholder value stated as priority: Management said it will drive shareholder value while executing its strategy and positioning the company for long-term success as an independent business. Source

2026 guidance

• Full-year 2026 sales and EBITDA guided: Full-year 2026 guidance: net sales of $3.9 billion to $4.1 billion and Adjusted EBITDA of $975 million to $1,025 million. Source
• Full-year EPS and capex guided: Full-year 2026 Adjusted Diluted EPS of $2.45 to $2.75 and capital expenditures of $400 million to $425 million. Source
• First-quarter 2026 guidance given: First-quarter 2026 net sales of $935 million to $985 million and Adjusted EBITDA of $235 million to $245 million. Source

Separation and standalone costs

• Full-year tax rose on separation: Full-year income tax expense was $362 million, up $170 million; net income attributable to Solstice was $237 million against $594 million. Source
• Quarterly income tax expense fell: Income tax expense was $32 million in the quarter, down $10 million on lower pre-tax income. Source
• Full-year standalone adjustments reduced: Full-year standalone adjustments were $43 million against $103 million a year earlier, in the reconciliation to Adjusted Standalone EBITDA. Source

Coming up, as management said on 11 February 2026

• Dividend payment date set: The $0.075 quarterly dividend is payable March 10, 2026 to holders of record on February 24, 2026. Source
• Guidance updated only when announced: Guidance is effective only as of its date and will be updated or affirmed only when the company publicly announces it. Source

Figures management reported

Risks management discussed

• Regulatory: Refrigerants margin is exposed to the ongoing transition to LGWP refrigerants, which shifts product mix and margin. Source
• Operational: Plant downtime and cost absorption weighed on margin in the quarter despite strong top-line growth. Source

Earlier plans management reported on

• Not stated: Management said it is delivering on its commitment to invest in capacity, technology and operating efficiency projects in high-growth areas. Source
• Not stated: Management attributed the fourth-quarter margin decline to previously anticipated factors, including transitory costs and the LGWP transition. Source
• Met: Management said its efforts to prepare to operate independently were completed for the October 2025 separation from Honeywell. Source

Other quarters

• Q2 FY2026 earnings call
• Q1 FY2026 earnings call
• Q3 FY2025 earnings call
• Q2 FY2025 results

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.